Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1998 Feb;152(2):373–378.

Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.

A B Schroeijers 1, G L Scheffer 1, M J Flens 1, G A Meijer 1, M A Izquierdo 1, P van der Valk 1, R J Scheper 1
PMCID: PMC1857981  PMID: 9466563

Abstract

Multidrug resistant cancer cells frequently overexpress the 110-kd lung resistance-related protein (LRP) as detected with the monoclonal antibody (MAb) LRP-56. Recently, we identified LRP as the major vault protein (MVP), which is the major constituent of vaults, multisubunit cellular organelles. Clinically, LRP/MVP expression in cancer at time of diagnosis provided a strong and independent prognostic factor for response to chemotherapy and outcome in different tumor types, notably acute myeloid leukemia and ovarian cancer. To facilitate additional immunohistopathological studies, we have optimized LRP/MVP detection in paraffin-embedded tissues using two monoclonal antibodies, LRP-56 and LMR-5. Blocking experiments showed that LRP-56 and LMR-5 MAbs detect different epitopes of LRP/MVP. Immunohistochemical studies with both MAbs in a panel of human multidrug resistant tumor cell lines, normal tissues, and colorectal tumors showed that LRP/MVP expression can be reliably detected after formalin-fixation and paraffm-embedding using overnight incubation at 4 degrees C with the primary MAbs at 5- to 10-fold higher concentrations (ie, 1 to 10 microg/ml) as currently used with frozen sections. Both streptavidin-biotin complex and alkaline phosphatase-anti-alkaline phosphatase techniques could be successfully used for signal-amplification. Staining quality did not benefit from antigen-retrieval pretreatments. The optimized staining methodology facilitates studies in archival material on the putative role of LRP/MVP in clinical drug resistance.

Full text

PDF
373

Images in this article

376Figure 1
on p.376

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck W. T., Grogan T. M., Willman C. L., Cordon-Cardo C., Parham D. M., Kuttesch J. F., Andreeff M., Bates S. E., Berard C. W., Boyett J. M. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res. 1996 Jul 1;56(13):3010–3020. [PubMed] [Google Scholar]
  2. Bittl A., Nap M., Jäger W., Cornillie F., Lang N. Immunohistochemical detection of P-glycoprotein on frozen and paraffin-embedded tissue sections of normal and malignant tissues. Anticancer Res. 1995 May-Jun;15(3):1007–1014. [PubMed] [Google Scholar]
  3. Cordon-Cardo C., O'Brien J. P., Boccia J., Casals D., Bertino J. R., Melamed M. R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem. 1990 Sep;38(9):1277–1287. doi: 10.1177/38.9.1974900. [DOI] [PubMed] [Google Scholar]
  4. Dingemans A. M., van Ark-Otte J., van der Valk P., Apolinario R. M., Scheper R. J., Postmus P. E., Giaccone G. Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues. Ann Oncol. 1996 Aug;7(6):625–630. doi: 10.1093/oxfordjournals.annonc.a010681. [DOI] [PubMed] [Google Scholar]
  5. Flens M. J., Scheffer G. L., van der Valk P., Broxterman H. J., Eijdems E. W., Huysmans A. C., Izquierdo M. A., Scheper R. J. Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies. Int J Cancer. 1997 Oct 9;73(2):249–257. doi: 10.1002/(sici)1097-0215(19971009)73:2<249::aid-ijc15>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  6. Flens M. J., Zaman G. J., van der Valk P., Izquierdo M. A., Schroeijers A. B., Scheffer G. L., van der Groep P., de Haas M., Meijer C. J., Scheper R. J. Tissue distribution of the multidrug resistance protein. Am J Pathol. 1996 Apr;148(4):1237–1247. [PMC free article] [PubMed] [Google Scholar]
  7. Izquierdo M. A., Scheffer G. L., Flens M. J., Giaccone G., Broxterman H. J., Meijer C. J., van der Valk P., Scheper R. J. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol. 1996 Mar;148(3):877–887. [PMC free article] [PubMed] [Google Scholar]
  8. Izquierdo M. A., Shoemaker R. H., Flens M. J., Scheffer G. L., Wu L., Prather T. R., Scheper R. J. Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int J Cancer. 1996 Jan 17;65(2):230–237. doi: 10.1002/(SICI)1097-0215(19960117)65:2<230::AID-IJC17>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  9. Izquierdo M. A., van der Zee A. G., Vermorken J. B., van der Valk P., Beliën J. A., Giaccone G., Scheffer G. L., Flens M. J., Pinedo H. M., Kenemans P. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst. 1995 Aug 16;87(16):1230–1237. doi: 10.1093/jnci/87.16.1230. [DOI] [PubMed] [Google Scholar]
  10. List A. F., Spier C. S., Grogan T. M., Johnson C., Roe D. J., Greer J. P., Wolff S. N., Broxterman H. J., Scheffer G. L., Scheper R. J. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood. 1996 Mar 15;87(6):2464–2469. [PubMed] [Google Scholar]
  11. MacFarland A., Abramovich D. R., Ewen S. W., Pearson C. K. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta. Histochem J. 1994 May;26(5):417–423. doi: 10.1007/BF00160054. [DOI] [PubMed] [Google Scholar]
  12. Schadendorf D., Makki A., Stahr C., van Dyck A., Wanner R., Scheffer G. L., Flens M. J., Scheper R., Henz B. M. Membrane transport proteins associated with drug resistance expressed in human melanoma. Am J Pathol. 1995 Dec;147(6):1545–1552. [PMC free article] [PubMed] [Google Scholar]
  13. Scheffer G. L., Wijngaard P. L., Flens M. J., Izquierdo M. A., Slovak M. L., Pinedo H. M., Meijer C. J., Clevers H. C., Scheper R. J. The drug resistance-related protein LRP is the human major vault protein. Nat Med. 1995 Jun;1(6):578–582. doi: 10.1038/nm0695-578. [DOI] [PubMed] [Google Scholar]
  14. Scheper R. J., Broxterman H. J., Scheffer G. L., Kaaijk P., Dalton W. S., van Heijningen T. H., van Kalken C. K., Slovak M. L., de Vries E. G., van der Valk P. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 1993 Apr 1;53(7):1475–1479. [PubMed] [Google Scholar]
  15. Zijlstra J. G., de Vries E. G., Mulder N. H. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 1987 Apr 1;47(7):1780–1784. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES